Polymorphisms in dipeptidyl peptidase 4 reduce host cell entry of Middle East respiratory syndrome coronavirus

Middle East respiratory syndrome (MERS) coronavirus (MERS-CoV) causes a severe respiratory disease in humans. The MERS-CoV spike (S) glycoprotein mediates viral entry into target cells. For this, MERS-CoV S engages the host cell protein dipeptidyl peptidase 4 (DPP4, CD26) and the interface between M...

Full description

Saved in:
Bibliographic Details
Main Authors: Hannah Kleine-Weber, Simon Schroeder, Nadine Krüger, Alexander Prokscha, Hassan Y. Naim, Marcel A. Müller, Christian Drosten, Stefan Pöhlmann, Markus Hoffmann
Format: Article
Language:English
Published: Taylor & Francis Group 2020-01-01
Series:Emerging Microbes and Infections
Subjects:
Online Access:https://www.tandfonline.com/doi/10.1080/22221751.2020.1713705
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850200654518157312
author Hannah Kleine-Weber
Simon Schroeder
Nadine Krüger
Alexander Prokscha
Hassan Y. Naim
Marcel A. Müller
Christian Drosten
Stefan Pöhlmann
Markus Hoffmann
author_facet Hannah Kleine-Weber
Simon Schroeder
Nadine Krüger
Alexander Prokscha
Hassan Y. Naim
Marcel A. Müller
Christian Drosten
Stefan Pöhlmann
Markus Hoffmann
author_sort Hannah Kleine-Weber
collection DOAJ
description Middle East respiratory syndrome (MERS) coronavirus (MERS-CoV) causes a severe respiratory disease in humans. The MERS-CoV spike (S) glycoprotein mediates viral entry into target cells. For this, MERS-CoV S engages the host cell protein dipeptidyl peptidase 4 (DPP4, CD26) and the interface between MERS-CoV S and DPP4 has been resolved on the atomic level. Here, we asked whether naturally-occurring polymorphisms in DPP4, that alter amino acid residues required for MERS-CoV S binding, influence cellular entry of MERS-CoV. By screening of public databases, we identified fourteen such polymorphisms. Introduction of the respective mutations into DPP4 revealed that all except one (Δ346-348) were compatible with robust DPP4 expression. Four polymorphisms (K267E, K267N, A291P and Δ346-348) strongly reduced binding of MERS-CoV S to DPP4 and S protein-driven host cell entry, as determined using soluble S protein and S protein bearing rhabdoviral vectors, respectively. Two polymorphisms (K267E and A291P) were analyzed in the context of authentic MERS-CoV and were found to attenuate viral replication. Collectively, we identified naturally-occurring polymorphisms in DPP4 that negatively impact cellular entry of MERS-CoV and might thus modulate MERS development in infected patients.
format Article
id doaj-art-6c0d81b7e961460e8a7dc357695bbdf0
institution OA Journals
issn 2222-1751
language English
publishDate 2020-01-01
publisher Taylor & Francis Group
record_format Article
series Emerging Microbes and Infections
spelling doaj-art-6c0d81b7e961460e8a7dc357695bbdf02025-08-20T02:12:15ZengTaylor & Francis GroupEmerging Microbes and Infections2222-17512020-01-019115516810.1080/22221751.2020.1713705Polymorphisms in dipeptidyl peptidase 4 reduce host cell entry of Middle East respiratory syndrome coronavirusHannah Kleine-Weber0Simon Schroeder1Nadine Krüger2Alexander Prokscha3Hassan Y. Naim4Marcel A. Müller5Christian Drosten6Stefan Pöhlmann7Markus Hoffmann8Infection Biology Unit, German Primate Center, Göttingen, GermanyCharité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Institute of Virology, Berlin, GermanyInstitute of Virology, University of Veterinary Medicine Hannover, Hannover, GermanyDepartment of Physiological Chemistry, University of Veterinary Medicine Hannover, Hannover, GermanyDepartment of Physiological Chemistry, University of Veterinary Medicine Hannover, Hannover, GermanyCharité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Institute of Virology, Berlin, GermanyCharité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Institute of Virology, Berlin, GermanyInfection Biology Unit, German Primate Center, Göttingen, GermanyInfection Biology Unit, German Primate Center, Göttingen, GermanyMiddle East respiratory syndrome (MERS) coronavirus (MERS-CoV) causes a severe respiratory disease in humans. The MERS-CoV spike (S) glycoprotein mediates viral entry into target cells. For this, MERS-CoV S engages the host cell protein dipeptidyl peptidase 4 (DPP4, CD26) and the interface between MERS-CoV S and DPP4 has been resolved on the atomic level. Here, we asked whether naturally-occurring polymorphisms in DPP4, that alter amino acid residues required for MERS-CoV S binding, influence cellular entry of MERS-CoV. By screening of public databases, we identified fourteen such polymorphisms. Introduction of the respective mutations into DPP4 revealed that all except one (Δ346-348) were compatible with robust DPP4 expression. Four polymorphisms (K267E, K267N, A291P and Δ346-348) strongly reduced binding of MERS-CoV S to DPP4 and S protein-driven host cell entry, as determined using soluble S protein and S protein bearing rhabdoviral vectors, respectively. Two polymorphisms (K267E and A291P) were analyzed in the context of authentic MERS-CoV and were found to attenuate viral replication. Collectively, we identified naturally-occurring polymorphisms in DPP4 that negatively impact cellular entry of MERS-CoV and might thus modulate MERS development in infected patients.https://www.tandfonline.com/doi/10.1080/22221751.2020.1713705Middle East respiratory syndrome coronavirusspike glycoproteindipeptidyl peptidase 4polymorphismsreceptor binding
spellingShingle Hannah Kleine-Weber
Simon Schroeder
Nadine Krüger
Alexander Prokscha
Hassan Y. Naim
Marcel A. Müller
Christian Drosten
Stefan Pöhlmann
Markus Hoffmann
Polymorphisms in dipeptidyl peptidase 4 reduce host cell entry of Middle East respiratory syndrome coronavirus
Emerging Microbes and Infections
Middle East respiratory syndrome coronavirus
spike glycoprotein
dipeptidyl peptidase 4
polymorphisms
receptor binding
title Polymorphisms in dipeptidyl peptidase 4 reduce host cell entry of Middle East respiratory syndrome coronavirus
title_full Polymorphisms in dipeptidyl peptidase 4 reduce host cell entry of Middle East respiratory syndrome coronavirus
title_fullStr Polymorphisms in dipeptidyl peptidase 4 reduce host cell entry of Middle East respiratory syndrome coronavirus
title_full_unstemmed Polymorphisms in dipeptidyl peptidase 4 reduce host cell entry of Middle East respiratory syndrome coronavirus
title_short Polymorphisms in dipeptidyl peptidase 4 reduce host cell entry of Middle East respiratory syndrome coronavirus
title_sort polymorphisms in dipeptidyl peptidase 4 reduce host cell entry of middle east respiratory syndrome coronavirus
topic Middle East respiratory syndrome coronavirus
spike glycoprotein
dipeptidyl peptidase 4
polymorphisms
receptor binding
url https://www.tandfonline.com/doi/10.1080/22221751.2020.1713705
work_keys_str_mv AT hannahkleineweber polymorphismsindipeptidylpeptidase4reducehostcellentryofmiddleeastrespiratorysyndromecoronavirus
AT simonschroeder polymorphismsindipeptidylpeptidase4reducehostcellentryofmiddleeastrespiratorysyndromecoronavirus
AT nadinekruger polymorphismsindipeptidylpeptidase4reducehostcellentryofmiddleeastrespiratorysyndromecoronavirus
AT alexanderprokscha polymorphismsindipeptidylpeptidase4reducehostcellentryofmiddleeastrespiratorysyndromecoronavirus
AT hassanynaim polymorphismsindipeptidylpeptidase4reducehostcellentryofmiddleeastrespiratorysyndromecoronavirus
AT marcelamuller polymorphismsindipeptidylpeptidase4reducehostcellentryofmiddleeastrespiratorysyndromecoronavirus
AT christiandrosten polymorphismsindipeptidylpeptidase4reducehostcellentryofmiddleeastrespiratorysyndromecoronavirus
AT stefanpohlmann polymorphismsindipeptidylpeptidase4reducehostcellentryofmiddleeastrespiratorysyndromecoronavirus
AT markushoffmann polymorphismsindipeptidylpeptidase4reducehostcellentryofmiddleeastrespiratorysyndromecoronavirus